Нүүр зураг

Small-molecule compounds inhibiting S-phase kinase-associated protein 2: A review

S-phase kinase-associated protein 2 (Skp2) is a substrate-specific adaptor in Skp1-CUL1-ROC1-F-box E3 ubiquitin ligases and widely regarded as an oncogene. Therefore, Skp2 has remained as an active anticancer research topic since its discovery. Accordingly, the structure of Skp2 has been solved and...

Бүрэн тодорхойлолт

-д хадгалсан:

Номзүйн дэлгэрэнгүй
Үндсэн зохиолчид:	Jia Jing (Зохиогч), Li Rui (Зохиогч), Sun Junyuan (Зохиогч), Yang Jinfeng (Зохиогч), Hong Zhihao (Зохиогч), Lu Weiguo (Зохиогч), Jia Zhenyu (Зохиогч)
Формат:	Ном
Хэвлэсэн:	Frontiers Media S.A., 2023-04-01T00:00:00Z.
Нөхцлүүд:	article
Онлайн хандалт:	Connect to this object online.
Шошгууд:	Шошго нэмэх Шошго байхгүй, Энэхүү баримтыг шошголох эхний хүн болох!

Ижил төстэй зүйлс

Usage of Mitogen-Activated Protein Kinase Small Molecule Inhibitors: More Than Just Inhibition!
-н: Steffen K. Meurer, зэрэг
Хэвлэсэн: (2018)

Inhibiting Cytoprotective Autophagy in Cancer Therapy: An Update on Pharmacological Small-Molecule Compounds
-н: Lijuan Zhang, зэрэг
Хэвлэсэн: (2022)

Iterative Upgrading of Small Molecular Tyrosine Kinase Inhibitors for EGFR Mutation in NSCLC: Necessity and Perspective
-н: Jing Zhu, зэрэг
Хэвлэсэн: (2021)

Commentary: Usage of Mitogen-Activated Protein Kinase Small Molecule Inhibitors: More Than Just Inhibition!
-н: Marius Pollet, зэрэг
Хэвлэсэн: (2018)

Therapeutic Potential of Nitrogen Mustard Based Hybrid Molecules
-н: Yiming Chen, зэрэг
Хэвлэсэн: (2018)

Properties of FDA-approved small molecule protein kinase inhibitors: A 2024 update
-н: Robert Roskoski, Jr
Хэвлэсэн: (2024)

Rule of five violations among the FDA-approved small molecule protein kinase inhibitors
-н: Robert Roskoski, Jr
Хэвлэсэн: (2023)

Small molecule protein kinase inhibitors approved by regulatory agencies outside of the United States
-н: Robert Roskoski Jr
Хэвлэсэн: (2023)

Baricitinib: A 2018 Novel FDA-Approved Small Molecule Inhibiting Janus Kinases
-н: Annie Mayence, зэрэг
Хэвлэсэн: (2019)

Computer-Aided Identification of Kinase-Targeted Small Molecules for Cancer: A Review on AKT Protein
-н: Erika Primavera, зэрэг
Хэвлэсэн: (2023)

Duvelisib: A 2018 Novel FDA-Approved Small Molecule Inhibiting Phosphoinositide 3-Kinases
-н: Daniel A. Rodrigues, зэрэг
Хэвлэсэн: (2019)

Development of small-molecule tropomyosin receptor kinase (TRK) inhibitors for NTRK fusion cancers
-н: Tingting Jiang, зэрэг
Хэвлэсэн: (2021)

Study on the Characteristics of Small-Molecule Kinase Inhibitors-Related Drug-Induced Liver Injury
-н: Huiqun Dong, зэрэг
Хэвлэсэн: (2022)

Small molecules targeting protein-protein interactions for cancer therapy
-н: Defa Wu, зэрэг
Хэвлэсэн: (2023)

Development of small molecule extracellular signal-regulated kinases (ERKs) inhibitors for cancer therapy
-н: Xiaoli Pan, зэрэг
Хэвлэсэн: (2022)

Impact of Selected Small-Molecule Kinase Inhibitors on Lipid Membranes
-н: Meike Luck, зэрэг
Хэвлэсэн: (2021)

Small molecule inhibitors of cyclin-dependent kinase 9 for cancer therapy
-н: Aisha Alsfouk
Хэвлэсэн: (2021)

Molecular glues modulate protein functions by inducing protein aggregation: A promising therapeutic strategy of small molecules for disease treatment
-н: Hongyu Wu, зэрэг
Хэвлэсэн: (2022)

Therapeutic strategies of targeting non-apoptotic regulated cell death (RCD) with small-molecule compounds in cancer
-н: Xin Jin, зэрэг
Хэвлэсэн: (2024)

Targeting autophagy using small-molecule compounds to improve potential therapy of Parkinson's disease
-н: Kai Zhang, зэрэг
Хэвлэсэн: (2021)

Cost in the United States of FDA-approved small molecule protein kinase inhibitors used in the treatment of neoplastic and non-neoplastic diseases
-н: Robert Roskoski, Jr
Хэвлэсэн: (2024)

Glycaemic abnormalities induced by small molecule tryosine kinase inhibitors: a review
-н: Takudzwa Mugiya, зэрэг
Хэвлэсэн: (2024)

Identification of a Small Molecule That Inhibits the Interaction of LPS Transporters LptA and LptC
-н: Xiaowei Dai, зэрэг
Хэвлэсэн: (2022)

Beyond Small Molecules: Antibodies and Peptides for Fibroblast Activation Protein Targeting Radiopharmaceuticals
-н: Xiaona Sun, зэрэг
Хэвлэсэн: (2024)

Small-molecule inhibitors of kinases in breast cancer therapy: recent advances, opportunities, and challenges
-н: Isha Bansal, зэрэг
Хэвлэсэн: (2023)

Identification and characterization of the Cucurbitacins, a novel class of small-molecule inhibitors of Tropomyosin receptor kinase a
-н: Yueling Zhong, зэрэг
Хэвлэсэн: (2019)

Expanding the horizons of targeted protein degradation: A non-small molecule perspective
-н: Xiaowei Huang, зэрэг
Хэвлэсэн: (2024)

Therapeutic strategies of glioblastoma (GBM): The current advances in the molecular targets and bioactive small molecule compounds
-н: Hui Liu, зэрэг
Хэвлэсэн: (2022)

Discovery of small molecule Gαq/11 protein inhibitors against uveal melanoma
-н: Yang Ge, зэрэг
Хэвлэсэн: (2022)

Targeting Protein-Protein Interactions to Inhibit Cyclin-Dependent Kinases
-н: Mark Klein
Хэвлэсэн: (2023)

Targeting Th17 Cells with Small Molecules and Small Interference RNA
-н: Hui Lin, зэрэг
Хэвлэсэн: (2015)

Structure-based virtual screening for the inhibition and clearance of amyloidosis by small molecules as pharmacological chaperones
-н: Fantao Sun, зэрэг
Хэвлэсэн: (2023)

A Comprehensive Review of Clinical Cardiotoxicity Incidence of FDA-Approved Small-Molecule Kinase Inhibitors
-н: Ying Jin, зэрэг
Хэвлэсэн: (2020)

Tyrosine kinase inhibitors: new molecules in non-small cell lung cancer (EGFR AND ALK)
-н: Fernando Franco, зэрэг
Хэвлэсэн: (2017)

Phosphatase-independent functions of SHP2 and its regulation by small molecule compounds
-н: Wenjie Guo, зэрэг
Хэвлэсэн: (2020)

An Updated Overview on the Role of Small Molecules and Natural Compounds in the "Young Science" of Rejuvenation
-н: Giovanni Ribaudo, зэрэг
Хэвлэсэн: (2023)

Protein tyrosine kinase but not protein kinase C inhibition blocks receptor induced alveolar macrophage activation
-н: K. Pollock, зэрэг
Хэвлэсэн: (1993)

Exploring Small Molecules Targeting Protein-Protein Interactions (PPIs): Advancements and Future Prospects
-н: Sachin P. Patil
Хэвлэсэн: (2023)

Phase I pharmacokinetic study of an oral, small-molecule MEK inhibitor tunlametinib in patients with advanced NRAS mutant melanoma
-н: Qian Zhao, зэрэг
Хэвлэсэн: (2022)

Non-small molecule PROTACs (NSM-PROTACs): Protein degradation kaleidoscope
-н: Sinan Ma, зэрэг
Хэвлэсэн: (2022)